Exane Derivatives’s NetEase NTES Stock Holding History

Exane Derivatives’s Portfolio NTES Stock Details NTES Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$99.6K	Sell	1,067 -3,760	-78%	-$358K	0.06%	264
2022 Q1	$433K	Buy	4,827 +211	+5%	+$20.1K	0.12%	207
2021 Q4	$470K	Buy	4,616 +4,104	+802%	+$417K	0.11%	186
2021 Q3	$43.7K	Sell	512 -525	-51%	-$49.6K	0.01%	630
2021 Q2	$116K	Sell	1,037 -890	-46%	-$98K	0.03%	523
2021 Q1	$199K	Buy	+1,927	New	+$218K	0.06%	299
2020 Q3	–	Sell	-900	Closed	-$77.3K	–	770
2020 Q2	$77.3K	Hold	900	–	–	0.02%	321
2020 Q1	$57.8K	Buy	900 +415	+86%	+$27.3K	0.02%	346
2019 Q4	$33.5K	Buy	+485	New	+$28.4K	0.01%	373

Other funds holding NTES

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GAMH

Greenwoods Asset Management (HK) Hong Kong $2.19B AUM 50.16% 1-Year Est. Return

Exane Derivatives's NTES Position: Q2 2022 in Review

Exane Derivatives reduced its NetEase (NTES) stake by 78% in Q2 2022, selling an estimated $358K and leaving 1,067 shares worth $99.6K. The position accounts for 0.06% of the portfolio, ranked #264.

Exane Derivatives first reported a position in NTES in Q4 2019 and has held it in 9 quarters since. The position peaked at $470K in Q4 2021. 360 funds tracked by Wall St. Rank hold NTES as of Q2 2022.

Exane Derivatives held 1,067 shares of NetEase worth $99.6K as of Q2 2022.
Exane Derivatives sold 3,760 NetEase shares in Q2 2022, an estimated $358K.
NetEase made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #264 holding.
Exane Derivatives first reported a position in NetEase in Q4 2019 and has held it in 9 quarters since.
Exane Derivatives's NetEase position peaked at $470K in Q4 2021.
360 funds tracked by Wall St. Rank held NetEase as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.